Chemcrux Enterprises (CHEMCRUX)₹78.73−0.54%Specialty Chemicals
In the Jun 2026 quarter (consolidated), Chemcrux Enterprises reported sales of ₹22.01 Cr, up 32.9% from Jun 2025, and net profit of ₹0.52 Cr, up 420.0% year on year. For the year to Mar 2026, sales were ₹80.93 Cr and net profit ₹3.74 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.89 | 21.89 | 18.60 | 17.16 | 17.82 | 19.46 | 15.77 | 16.56 | 17.79 | 22.16 | 24.37 | 22.01 |
| Expenses | 13.47 | 17.41 | 15.88 | 15.01 | 15.36 | 16.70 | 13.57 | 14.84 | 15.93 | 18.55 | 20.06 | 19.21 |
| Operating Profit | 2.35 | 4.39 | 2.63 | 2.07 | 2.37 | 2.70 | 2.12 | 1.64 | 1.80 | 3.54 | 4.20 | 2.71 |
| OPM % | 14.7% | 20.0% | 14.1% | 12.0% | 13.2% | 13.8% | 13.4% | 9.8% | 10.0% | 15.9% | 17.2% | 12.2% |
| Other Income | 0.23 | 0.55 | 0.34 | 0.40 | 0.25 | 0.60 | 0.23 | 0.43 | 0.64 | 0.59 | 0.35 | 0.10 |
| Interest | 0.22 | 0.18 | 0.14 | 0.14 | 0.34 | 0.61 | 0.70 | 0.87 | 0.84 | 0.77 | 0.71 | 0.65 |
| Depreciation | 0.59 | 0.59 | 0.56 | 0.57 | 0.74 | 0.93 | 1.00 | 1.19 | 1.21 | 1.20 | 1.18 | 1.19 |
| Profit before tax | 1.80 | 4.20 | 2.30 | 1.77 | 1.57 | 1.79 | 0.68 | 0.04 | 0.40 | 2.19 | 2.68 | 1.00 |
| Tax % | 30.1% | 36.7% | 3.5% | 29.5% | 26.2% | 25.8% | 68.6% | −233.4% | 46.1% | 27.9% | 30.6% | 48.4% |
| Net Profit | 1.25 | 2.67 | 2.22 | 1.25 | 1.16 | 1.33 | 0.22 | 0.10 | 0.22 | 1.59 | 1.86 | 0.52 |
| EPS (Rs) | 0.83 | 1.79 | 1.48 | 0.83 | 0.77 | 0.88 | 0.13 | 0.05 | 0.15 | 1.06 | 1.24 | 0.33 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|
| Sales | 95.55 | 95.47 | 78.71 | 70.23 | 80.93 | 86.33 |
| Expenses | 74.42 | 73.57 | 64.96 | 60.62 | 69.35 | 73.75 |
| Operating Profit | 20.79 | 21.53 | 13.42 | 9.26 | 11.19 | 12.25 |
| OPM % | 21.7% | 22.5% | 17.0% | 13.2% | 13.8% | 14.2% |
| Other Income | 0.99 | 1.06 | 1.17 | 1.48 | 2.01 | 1.68 |
| Interest | 0.18 | 0.83 | 0.84 | 1.76 | 3.16 | 2.97 |
| Depreciation | 1.60 | 2.05 | 2.30 | 3.22 | 4.74 | 4.78 |
| Profit before tax | 20.01 | 19.71 | 11.45 | 5.77 | 5.30 | 6.27 |
| Tax % | 25.4% | 26.9% | 26.1% | 32.1% | 29.2% | — |
| Exceptional items | 0.20 | 0.30 | 0.14 | 0.40 | 1.46 | — |
| Net Profit | 14.89 | 14.39 | 8.45 | 3.92 | 3.74 | 4.19 |
| EPS (Rs) | 10.02 | 9.69 | 5.69 | 2.63 | 2.51 | 2.78 |
| Dividend payout % | 20.0% | 20.7% | 17.6% | 37.9% | 39.8% | — |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 14.85 | 14.85 | 14.87 | 14.87 | 14.87 |
| Reserves | 39.89 | 51.64 | 57.52 | 59.94 | 62.08 |
| Borrowings | 9.73 | 14.39 | 26.41 | 42.28 | 34.30 |
| Other Liabilities | 19.25 | 12.31 | 11.16 | 10.17 | 16.30 |
| Total Liabilities | 83.72 | 93.19 | 110 | 127 | 128 |
| Fixed Assets | 25.53 | 33.17 | 33.18 | 77.27 | 75.10 |
| CWIP | 0.00 | 0.32 | 21.10 | 1.62 | 4.09 |
| Investments | 7.09 | 16.80 | 19.84 | 19.86 | 15.94 |
| Other Assets | 51.10 | 42.90 | 35.84 | 28.51 | 32.42 |
| Inventories | 11.55 | 14.08 | 8.40 | 10.01 | 6.10 |
| Trade receivables | 18.84 | 13.43 | 15.28 | 11.75 | 18.88 |
| Cash & equivalents | 11.91 | 7.11 | 5.19 | 1.16 | 2.58 |
| Total Assets | 83.72 | 93.19 | 110 | 127 | 128 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 9.18 | 14.84 | 16.36 | 7.61 | 13.87 |
| Cash from investing activity | −2.63 | −20.39 | −25.81 | −5.95 | −0.06 |
| Cash from financing activity | 3.97 | 0.97 | 7.65 | −5.67 | −12.38 |
| Net cash flow | 10.50 | −4.71 | −1.92 | −4.05 | 1.43 |
| Capex | 4.63 | 11.20 | 24.38 | 8.43 | 5.16 |
| Free cash flow | 4.60 | 3.72 | −6.86 | −0.65 | 8.75 |
| CFO / OP % | 69.1% | 86.1% | 142.1% | 98.1% | 136.1% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 72 | 52 | 71 | 61 | 86 |
| Inventory days | 92 | 125 | 100 | 135 | 69 |
| Days payable | 92 | 70 | 70 | 60 | 104 |
| Cash conversion cycle | 73 | 106 | 101 | 137 | 50 |
| Working capital days | 37 | 67 | 55 | 28 | 16 |
| ROCE % | — | 27.6% | 13.5% | 6.7% | 6.4% |
For the Jun 2026 quarter, Chemcrux Enterprises reported sales of ₹22.01 Cr, up 32.9% year on year and net profit of ₹0.52 Cr, up 420.0% year on year. The operating margin was 12.2%.
Chemcrux Enterprises' sales for the year to Mar 2026 were ₹80.93 Cr; over the last twelve months they were ₹86.33 Cr.
Net profit for the year to Mar 2026 was ₹3.74 Cr, and ₹4.19 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.78.
Chemcrux Enterprises reported borrowings of ₹34.30 Cr at Mar 2026, against cash and equivalents of ₹2.58 Cr.
Cash from operations was ₹13.87 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹8.75 Cr.